Many types of cells can express PD-L1, including tumor cells and immune cells after exposure to cytokines, while PD-L2 is expressed mainly on dendritic cells in normal tissues, making the PD-1/PD-L1 interaction more suitable to cancer therapies21. This evidence concerns the gene PDCD1LG2 and neoplasm.